Biocure Technology Inc. (CSE:CURE.X)
Canada flag Canada · Delayed Price · Currency is CAD
0.0350
0.00 (0.00%)
At close: Feb 26, 2026

Biocure Technology Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
10111427
Upgrade
Market Cap Growth
-96.60%-88.89%29.45%-92.14%-49.55%31.84%
Upgrade
Enterprise Value
10131731
Upgrade
Last Close Price
0.040.010.140.091.172.48
Upgrade
PB Ratio
0.440.120.88-0.47-16.26-11.87
Upgrade
P/TBV Ratio
0.440.120.88---
Upgrade
P/FCF Ratio
-11.42----
Upgrade
P/OCF Ratio
-11.42----
Upgrade
EV/FCF Ratio
-12.94----
Upgrade
Debt / Equity Ratio
0.040.040.03-0.04-4.45-1.72
Upgrade
Debt / FCF Ratio
-3.62----
Upgrade
Net Debt / Equity Ratio
0.000.020.02-0.02-4.26-1.70
Upgrade
Net Debt / EBITDA Ratio
----0.06-2.17-1.30
Upgrade
Net Debt / FCF Ratio
-0.082.31-0.17-0.05-3.35-3.00
Upgrade
Quick Ratio
0.140.040.030.010.050.03
Upgrade
Current Ratio
0.150.040.030.030.570.03
Upgrade
Return on Equity (ROE)
-18.02%-17.83%----
Upgrade
Return on Assets (ROA)
-7.49%-10.03%-32.40%-13.50%-24.91%-42.01%
Upgrade
Return on Capital Employed (ROCE)
-14.50%-22.90%-64.00%28.90%-432.10%-503.30%
Upgrade
Earnings Yield
-40.18%-167.53%-128.63%-133.13%-8.14%-10.72%
Upgrade
FCF Yield
-8.75%-15.40%-75.83%-7.82%-4.78%
Upgrade
Buyback Yield / Dilution
70.41%-1.23%13.15%-3.76%-4.98%-1.25%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.